Drug Profile
MK 0767
Alternative Names: KRP 297; MK 767Latest Information Update: 14 Sep 2004
Price :
$50
*
At a glance
- Originator Kyorin Pharmaceutical
- Developer Banyu; Kyorin Pharmaceutical
- Class Antihyperglycaemics; Small molecules; Thiazoles; Thiazolidinediones
- Mechanism of Action Peroxisome proliferator-activated receptor agonists; Peroxisome proliferator-activated receptor alpha agonists; Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus; Hyperlipidaemia
Most Recent Events
- 14 Sep 2004 Discontinued - Phase-II for Diabetes mellitus in Japan (PO)
- 14 Sep 2004 Discontinued - Preclinical for Hyperlipidaemia in Japan (PO)
- 04 Dec 2003 Phase-II clinical trials in Diabetes mellitus in Japan (PO)